Aliskiren/amlodipine/hydrochlorothiazide
Appearance
Combination of | |
---|---|
Aliskiren | Renin inhibitor |
Amlodipine | Calcium channel blocker |
Hydrochlorothiazide | Diuretic |
Clinical data | |
Trade names | Amturnide |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
PubChem CID | |
KEGG | |
Chemical and physical data | |
Formula | C57H86Cl2N8O15S2 |
Molar mass | 1258.38 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved in the United States on 21 December 2010.[1][2]
References
- ^ Amturnide approval letter. U.S. Food and Drug Administration (FDA).
- ^ "Drug Approval Package: Amturnide(amlodipine/aliskiren/hydrochlorothiazide) NDA #200045". U.S. Food and Drug Administration (FDA). 15 August 2011. Retrieved 27 August 2020.
{{cite web}}
: Unknown parameter|lay-url=
ignored (help)
External links
- "Aliskiren mixture with amlodipine and hydrochlorothiazide". Drug Information Portal. U.S. National Library of Medicine.